What is QuidelOrtho Corporation's R&D?

QuidelOrtho Corporation (QDEL) reported R&D of $44.9M in Q1 2026.

How has QuidelOrtho Corporation's R&D changed year-over-year?

QuidelOrtho Corporation's R&D decreased by 15.6% year-over-year, from $53.2M to $44.9M.

What is the long-term trend for QuidelOrtho Corporation's R&D?

Over 4 years (2021 to 2025), QuidelOrtho Corporation's R&D has grown at a 18.1% compound annual growth rate (CAGR), from $95.7M to $186.2M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

QuidelOrtho Corporation QDEL R&D

R&D at other companies

AbbottABT

$767M+7.1%

Bio-Rad LaboratoriesBIO

$62.9M-14.4%

DanaherDHR

$387M+2.1%

RevvityRVTY

$57.89M+8.0%

Opko HealthOPK

$29.2M-5.3%

Agilent TechnologiesA

$126M+12.5%

Other financials

Income statement

See full

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Balance sheet

See full

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total equity$1.9B-38.2%

Total assets$5.6B-12.9%

Cash flow

See full

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Valuation

See full

Market cap$921.94M-51.4%

Enterprise value$3.88B-20.1%

P/S0.4×-0.3×

Profitability

See full

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Returns & leverage

See full

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is QuidelOrtho Corporation's R&D?: QuidelOrtho Corporation (QDEL) reported R&D of $44.9M in Q1 2026.
How has QuidelOrtho Corporation's R&D changed year-over-year?: QuidelOrtho Corporation's R&D decreased by 15.6% year-over-year, from $53.2M to $44.9M.
What is the long-term trend for QuidelOrtho Corporation's R&D?: Over 4 years (2021 to 2025), QuidelOrtho Corporation's R&D has grown at a 18.1% compound annual growth rate (CAGR), from $95.7M to $186.2M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.